Cosmo and medtronic unveil the future of ai in gi: genius summit 2024 reveals innovations and collaborations that advance endoscopic care

Dublin, ireland--(newsfile corp. - april 12, 2024) - cosmo pharmaceuticals n.v. (six: copn) (fse: c43) (“cosmo”) announces that medtronic plc (nyse: mdt), a global leader in healthcare technology, presented at the genius summit 2024 the latest advancements in artificial intelligence (ai) for endoscopic care by unveiling colonpro™, the latest generation software for the gi genius™ intelligent endoscopy system developed by cosmo imd, along with a new strategic collaboration designed to enhance patient care.
MDT Ratings Summary
MDT Quant Ranking